Skip to main content
Clinical Trials/CTRI/2018/11/016366
CTRI/2018/11/016366
Not yet recruiting
未知

Comparision between intranasal dexmedetomidine, midazolam and ketamine as premedication for paediatric patients undergoing brain MRI: a prospective randomised double blind study - MRI- MAGNETIC RESONANCE IMAGING

I0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: G80-G83- Cerebral palsy and other paralytic syndromes
Sponsor
I
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • ASA\-PS 1 \&2

Exclusion Criteria

  • patients below 1 year of age
  • patients above 6 years of age
  • parents refusal to participate in the study
  • ASA\-PS 3 and above
  • any congenital heart disease
  • on beta blocker or digoxin therapy
  • any implants incompatible with MRI
  • patient requiring emergency MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials